We have congregated information in relation to stocks with the highest payout ratio as yet. The payout ratio in itself isn't a guarantee of good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know and anything around 60 percent is considered high.
1. National Retail Properties
169.26% Payout Ratio
National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases.
As maintained by Morningstar, Inc., the next dividend payment is on Oct 28, 2020, the estimated forward annual dividend rate is 2.08 and the estimated forward annual dividend yield is 5.24%.
National Retail Properties's sales growth this year is expected to be negative 1.5% and 2.7% for next year.
Year-on-year quarterly revenue growth declined by 5.9%, now sitting on 670.77M for the twelve trailing months.
National Retail Properties's sales growth for the current quarter is negative 5.6%. The company's growth estimates for the ongoing quarter and the next is 8.8% and 11.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.41%.
Volatility
National Retail Properties's last day, last week, and last month's average volatility was a positive 0.91%, a negative 0.42%, and a positive 0.12%, respectively.
National Retail Properties's last day, last week, and last month's high and low average amplitude percentage was 1.80%, 3.16%, and 2.74%, respectively.
National Retail Properties's Stock Yearly Top and Bottom Value
National Retail Properties's stock is valued at $40.09 at 19:23 EST, way below its 52-week high of $58.87 and way higher than its 52-week low of $24.04.
National Retail Properties's Moving Average
National Retail Properties's worth is above its 50-day moving average of $39.94 and above its 200-day moving average of $36.77.2. Eaton Vance Corporation Eaton Vance Tax
438.81% Payout Ratio
Eaton Vance Tax-Managed Buy-Write Opportunities Fund is a closed-ended equity mutual fund launched and managed by Eaton Vance Management.
According to Morningstar, Inc., the next dividend payment is on Sep 19, 2018, the estimated forward annual dividend rate is 1.33 and the estimated forward annual dividend yield is 8.85%.
Eaton Vance Corporation Eaton Vance Tax's sales growth this year is anticipated to be negative 0% and a negative 0% for next year.
Year-on-year quarterly revenue growth grew by 3.6%, now sitting on 19.72M for the twelve trailing months.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 1.64%.
Volatility
Eaton Vance Corporation Eaton Vance Tax's last day, last week, and last month's average volatility was a positive 0.87%, a negative 0.20%, and a positive 0.03%, respectively.
Eaton Vance Corporation Eaton Vance Tax's last day, last week, and last month's high and low average amplitude percentage was 1.33%, 1.49%, and 1.09%, respectively.
Eaton Vance Corporation Eaton Vance Tax's Stock Yearly Top and Bottom Value
Eaton Vance Corporation Eaton Vance Tax's stock is valued at $15.22 at 19:23 EST, under its 52-week high of $15.67 and way higher than its 52-week low of $8.59.
Eaton Vance Corporation Eaton Vance Tax's Moving Average
Eaton Vance Corporation Eaton Vance Tax's worth is above its 50-day moving average of $15.05 and above its 200-day moving average of $14.39.3. Universal Health Realty Income Trust
187.07% Payout Ratio
Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human service related facilities including acute care hospitals, rehabilitation hospitals, sub-acute care facilities, medical/office buildings, free-standing emergency departments and childcare centers.
As stated by Morningstar, Inc., the next dividend payment is on Dec 15, 2020, the estimated forward annual dividend rate is 2.78 and the estimated forward annual dividend yield is 4.26%.
Universal Health Realty Income Trust's sales growth this year is expected to be negative 0% and a negative 0% for next year.
Year-on-year quarterly revenue growth declined by 0.5%, now sitting on 78.87M for the twelve trailing months.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.69%.
Volatility
Universal Health Realty Income Trust's last day, last week, and last month's average volatility was a positive 0.37%, a positive 0.34%, and a negative 0.08%, respectively.
Universal Health Realty Income Trust's last day, last week, and last month's high and low average amplitude percentage was 2.96%, 4.37%, and 3.92%, respectively.
Universal Health Realty Income Trust's Stock Yearly Top and Bottom Value
Universal Health Realty Income Trust's stock is valued at $65.33 at 19:23 EST, way below its 52-week high of $132.41 and way above its 52-week low of $52.25.
Universal Health Realty Income Trust's Moving Average
Universal Health Realty Income Trust's value is below its 50-day moving average of $65.34 and higher than its 200-day moving average of $64.74.4. Ellington Residential Mortgage REIT
61.88% Payout Ratio
Ellington Residential Mortgage REIT, a real estate investment trust, specializes in acquiring, investing in, and managing residential mortgage-and real estate-related assets.
As maintained by Morningstar, Inc., the next dividend payment is on Dec 29, 2020, the estimated forward annual dividend rate is 1.12 and the estimated forward annual dividend yield is 8.82%.
Ellington Residential Mortgage REIT's sales growth this year is expected to be 55.9% and a negative 0% for next year.
Year-on-year quarterly revenue growth declined by 0%, now sitting on 600k for the twelve trailing months.
Ellington Residential Mortgage REIT's sales growth is 121.6% for the ongoing current quarter and 30.2% for the next. The company's growth estimates for the ongoing quarter and the next is 43.5% and 22.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.15%.
Volatility
Ellington Residential Mortgage REIT's last day, last week, and last month's average volatility was 0.16%, 0.03%, and 0.16%, respectively.
Ellington Residential Mortgage REIT's last day, last week, and last month's high and low average amplitude percentage was 1.91%, 2.86%, and 2.63%, respectively.
Ellington Residential Mortgage REIT's Stock Yearly Top and Bottom Value
Ellington Residential Mortgage REIT's stock is valued at $12.70 at 19:23 EST, under its 52-week high of $13.30 and way above its 52-week low of $2.70.
Ellington Residential Mortgage REIT's Moving Average
Ellington Residential Mortgage REIT's value is above its 50-day moving average of $12.46 and way above its 200-day moving average of $11.36.5. GlaxoSmithKline PLC
62.54% Payout Ratio
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally.
According to Morningstar, Inc., the next dividend payment is on Nov 11, 2020, the estimated forward annual dividend rate is 2.03 and the estimated forward annual dividend yield is 5.33%.
GlaxoSmithKline PLC's sales growth this year is anticipated to be 7.8% and 4.3% for next year.
Year-on-year quarterly revenue growth declined by 7.9%, now sitting on N/A for the twelve trailing months.
GlaxoSmithKline PLC's sales growth is 4.1% for the current ongoing quarter and 3.7% for the next. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 36.53%.
Volatility
GlaxoSmithKline PLC's last day, last week, and last month's average volatility was a negative 0.66%, a positive 0.56%, and a positive 0.06%, respectively.
GlaxoSmithKline PLC's last day, last week, and last month's high and low average amplitude percentage was 0.98%, 1.18%, and 1.18%, respectively.
GlaxoSmithKline PLC's Stock Yearly Top and Bottom Value
GlaxoSmithKline PLC's stock is valued at $38.34 at 19:23 EST, way below its 52-week high of $48.25 and way above its 52-week low of $31.43.
GlaxoSmithKline PLC's Moving Average
GlaxoSmithKline PLC's value is higher than its 50-day moving average of $37.15 and under its 200-day moving average of $38.53.6. James Hardie Industries plc
30.3% Payout Ratio
James Hardie Industries plc, together with its subsidiaries, manufactures and sells fiber cement siding and backer board products primarily in the United States, Canada, Australia, New Zealand, the Philippines, and Europe.
James Hardie Industries plc's sales growth this year is expected to be 9.7% and 6.6% for next year.
Year-on-year quarterly revenue growth grew by 11.6%, now sitting on 2.65B for the twelve trailing months.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.35%.
Volatility
James Hardie Industries plc's last day, last week, and last month's average volatility was a positive 0.95%, a negative 0.73%, and a positive 0.15%, respectively.
James Hardie Industries plc's last day, last week, and last month's high and low average amplitude percentage was 1.31%, 1.70%, and 1.32%, respectively.
James Hardie Industries plc's Stock Yearly Top and Bottom Value
James Hardie Industries plc's stock is valued at $28.62 at 19:23 EST, below its 52-week high of $30.00 and way higher than its 52-week low of $8.98.